Operated by the venture capital fund SOSV, IndieBio is the one of the world’s leading Biotech development program.

With facilities in both San Francisco and New York City, it offers entrepreneurs a holistic package during the 4-month intensive program, amounting to USD$525,000 in seed funding that includes laboratories, co-working space and dedicated mentorship. This is with the aim of startups becoming part of the wider IndieBio network, which includes alumni, investors, corporate partners and many more.

SOSV is a global venture capital firm that provides multi-stage investment to help start-ups develop and scale entrepreneurs’ big ideas for positive change. The programs offered by SOSV are focused on two areas, with the first being in pioneering technology that can strive for the betterment of the planet and humanity, and the second being in cross-border markets, most notably in Asia. SOSV invest in 150 companies every year through its own accelerator programs: HAX, IndieBio, Chinaccelerator, MOX and dlab.